Cancer Vaccine Produces 49% Melanoma Reduction in Patients Five Years Later

AI justification

Medical breakthrough with measurable, long-term health benefits and no identified ethical violations. | The development and validation of a cancer vaccine that significantly reduces melanoma recurrence and mortality represents a major advancement in public health and medical science. This innovation directly supports SDG 3 (Good Health and Well-being) by improving patient outcomes and reducing suffering. No ethical violations or negative aspects were identified in the described action.